PubMed HealthSearch

Biomedical subjects

S Saeger

Publications and source records attributed to S Saeger.

7 recordsLinked to original sources

Electrocatalytic glucose sensor.

An electrocatalytic glucose sensor for in vivo application has been developed. The sensor is a flow-through cell with three electrodes and can be integrated into a blood vessel. The principle of measurement is based on the direct electrochemical oxidation of glucose at a membrane-covered noble-metal electrode. To test the potential long-term in vivo function of the sensor, it was implanted in the carotid artery of a sheep. Thus, the sensor performance was verified over a period of 71 days. During this time, a nearly constant blood flow through the cell was achieved, which indicates good blood compatibility of the materials used. It was possible to set up a calibration that was valid over 24 days (mean error 2.3 mmol l-1). The tested cross-sensitivity of the sensor towards cysteine, acetyl salicylic acid and other small molecules shows tolerable effects on this type of glucose measurement. Only high concentrations of lactate and ethanol require a special adaptation of the calibration to suppress their influence. Minor cross-sensitivity and promising long-term stability recommend this type of sensor for in vivo monitoring of blood sugar level. However, for intravasal application, it is necessary to modify the present sensor design to a catheter-type construction.

Animals

In vivo experiment with the electrocatalytic glucose sensor in sheep.

In order to control the insulin dosage in diabetes therapy, an electrocatalytic glucose sensor for long-term implantation has been developed. To test the sensor function over a longer period, it was implanted as a flow-through cell in a sheep. The sensor was inserted into the carotid artery and driven by a portable electronic unit worn by the animal. The blood flow characteristics were nearly constant over the whole period of measurement. We were able to verify the sensor performance in one experiment lasting over 71 days. Stable calibrations of the sensor were achieved over longer periods of time, so that only a few calibrations are necessary in monitoring the blood glucose level during the whole period of implantation. It was thus possible to set up a calibration which was valid over 33 days (mean error 2.5 mM). These calibrations were not adversely affected by host reactions. The cross-sensitivity of the sensor was also verified, and it was found that the tested molecules did not significantly affect the sensor function. Only high concentrations of lactate and ethanol require a special adaptation of the calibration to suppress their influence. The sensor will be further improved to obtain a still longer calibration stability, and adapted for animal implantation, thus making it useful for clinical application.

Animals

[Development and evaluation of an electrocatalytic glucose sensor for diabetes therapy].

For the continuous measurement of glucose levels in vivo, an electrocatalytic glucose sensor has been developed. Electrochemical determination of the glucose concentration is effected by measurement of the impedance, which at given potentials is directly dependent on the glucose concentration in the solution. For evaluation and determination of long-term stability, the sensor was first implanted in the carotid artery in the form of a flow-through cell, and was later inserted into the vena cava of a sheep in the form of a catheter. Sensor response was checked periodically by performing glucose tolerance tests. During the implantation period, we also tested the sensitivity of the sensor towards various blood components and medicaments. By adapting sensor calibration, it proved possible to suppress these cross-sensitivity effects. The flow-through cell type of sensor remained functional for up to 71 days post-implantation. So far, data for the catheter-type sensor cover an indwelling time of up to 30 days.

Animals

Influence of paracetamol, sulfanilamide and ascorbic acid on the electrocatalytic glucose sensor.

An electrocatalytic glucose sensor for in vivo application has been developed. The principle of measurement is based on the direct electrochemical oxidation of glucose at a platinum electrode without an enzymatic reaction. In an in vivo experiment with sheep the glucose sensor was tested with respect to its cross-sensitivity towards ascorbic acid, paracetamol and sulfanilamide. The influence of these substances could be reduced by an adapted calibration to such an extent, that the sensor performance could be ensured.

Acetaminophen

Influence of urea on the glucose measurement by electrocatalytic sensor in the extracorporeal blood circulation of a sheep.

In an animal experiment with the electrocatalytic glucose sensor, measurements were carried out over one week in the extracorporeal circulation of a sheep. Glucose tolerance tests were performed, and the influence of increased urea concentrations in the blood on the glucose determination was investigated. The sensor constructed as a flow-through cell was integrated via a vascular graft outside the body into the carotid artery of the animal and activated by an external electronic unit of measurement. The glucose concentration was determined by measuring the impedance of the electrode/membrane system at various potentials. By means of a subsequent correlation analysis of the measured values obtained over one week, a calibration valid for the entire measurement period was established. After a zero adjustment, it was even possible to adopt the calibration from the glucose measurement of the preceding animal experiment. The investigations of the influence of urea on the glucose measurement showed that the error in measurement of the sensor, which is 20% on average, is only insignificantly increased when the urea level is raised beyond the maximum physiological concentration.

Animals

In vitro measurements with electrocatalytic glucose sensor in blood.

The principle of measurement with electrocatalytic glucose sensor is based on the direct electrochemical oxidation of glucose at an active and membrane-covered noble metal electrode. The objective is to measure glucose in the range of diffusion limiting current, since the glucose concentration in front of the membrane is proportional to the oxidative current. The determination of glucose concentration is realized by considering the electrode processes taking place at different potentials, and by measuring the impedance of the electrode/membrane system using the conventional three-electrode arrangement. Performance and long-term stability of the sensor are mainly dependent on the properties of the membrane and on the poisoning reactions at the electrode. Using this method, measurements were carried out in defibrinated sheep blood at 37 degrees C. After reproducible in vitro measurements could be made with the sensor over up to 3 weeks with an error of 20%, experiments were conducted in sheep using an extracorporeal circulation system. The correlation between the electrode signal and the glucose concentration in blood could be confirmed during glucose tolerance tests.

Animals

An electrocatalytic glucose sensor for in-vivo application.

An electrocatalytic sensor was developed for continuous measurement of glucose in circulating blood. The sensor is constructed as a flow-through cell that can be integrated into a blood vessel. The principle of measurement is based on the electrochemical oxidation of glucose at an active noble metal electrode. Selectivity is achieved by covering the sensing electrode with a diffusion-limiting membrane and by analyzing the impedance of the electrode/membrane system. The real and the imaginary parts of the impedance at certain potentials are directly proportional to the glucose concentration in the blood. These parameters are used in calculating the blood glucose concentration. To test the sensor, an in-vivo experiment was conducted in a sheep. The sensor's performance remained reliable 71 days after its implantation.

Animals